Atrium

Atrium Announces New Automated Insights Engine to Accelerate Adoption of Data-Driven Sales Management

Retrieved on: 
Wednesday, January 26, 2022
KPI-driven code analysis, Pressure, Craft Ventures, SalesLoft, VP, First Round Capital, Multimedia, Motion, SAN, Entrepreneurship, Heart, Charles River Ventures, Goal, Anomaly, CRM, CEO, Sales, Management, Online shopping, Atrium

Unfortunately, most sales managers aren't equipped with the tools to measure, manage, and improve their team's performance.

Key Points: 
  • Unfortunately, most sales managers aren't equipped with the tools to measure, manage, and improve their team's performance.
  • The Automated Insights Engine is available immediately to all customers of the Atrium Data-Driven Sales Management platform.
  • Atrium provides a Data-Driven Sales Management platform that empowers sales managers to improve team performance.
  • use the dashboards, goals, insights and alerts in the Atrium platform to hit their sales productivity and revenue goals.

EQS-News: Atrium European Real Estate Limited: Expiry of objections period in respect of the Merger between Atrium and Gazit Hercules 2020 Limited

Retrieved on: 
Friday, January 14, 2022
Company, Mergers and acquisitions, Part, Jersey Evening Post, Court, Acquisition, Prejudice, Gazit, Private law, British Virgin Islands company law, Security (finance), Holding company, NewCo, Atrium

Atrium European Real Estate Limited: Expiry of objections period in respect of the Merger between Atrium and Gazit Hercules 2020 Limited

Key Points: 
  • Atrium European Real Estate Limited: Expiry of objections period in respect of the Merger between Atrium and Gazit Hercules 2020 Limited
    The issuer is solely responsible for the content of this announcement.
  • Jersey, 14 January 2022 - On 23 December 2021, the shareholders of Atrium European Real Estate Limited (VSE/Euronext: ATRS), ("Atrium" or the "Company") approved the terms of the proposed merger between Atrium and Gazit Hercules 2020 Limited ("Newco"), which is an indirect wholly-owned subsidiary of Gazit-Globe Ltd ("Gazit") (the "Acquisition").
  • Post-completion of the Merger, Atrium will continue as the surviving entity, wholly-owned by Gazit.
  • Full details of the Merger are contained in the circular published by Atrium on 23 November 2021 (the "Shareholder Circular").

ONE OF THE MOST UNIQUE AND ECO-FRIENDLY STORES IN CALIFORNIA IS A GALLERY ART CAFE THAT SERVES ART NOT FOOD AT YOUR TABLE

Retrieved on: 
Wednesday, December 29, 2021
Creativity, Monday, Knowledge, Multimedia, CEO, Invention, Gallery, Sustainability, Electronics, Creative industries, Atrium

SACRAMENTO, Calif., Dec. 28, 2021 /PRNewswire/ --Inside the Atrium 916 gallery called Sacramento.Shop you will find upcycled, eco-friendly unique art and innovative products with a zero-waste twist.

Key Points: 
  • SACRAMENTO, Calif., Dec. 28, 2021 /PRNewswire/ --Inside the Atrium 916 gallery called Sacramento.Shop you will find upcycled, eco-friendly unique art and innovative products with a zero-waste twist.
  • Wallets and messenger bags made out of tires, reusable water balloons and even a Chinese takeout container that has been converted into an amp and battery-operated blue tooth speaker.
  • From clothes to electronics, wall art to kitchen wares, the Atrium Gallery Store inspires creativity and ingenuity.
  • Atrium 916 is open 6 days a week from 10am to 5pm, closed on Mondays.

UPDATE - Y-mAbs Announces Pipeline Update

Retrieved on: 
Wednesday, December 15, 2021
Therapy, Melanoma, Doctor of Philosophy, Private Securities Litigation Reform Act, Cardiac arrest, Neoplasm, Bone marrow, MBA, Squamous cell carcinoma, Antibody, FDA, Neuroblastoma, Cancer, Stridor, Growth, Adult, Hospital, Wernicke encephalopathy, Atrium, SVP, Memorial Sloan Kettering Cancer Center, Safety, Risk, GLOBE, Sarcoma, Granulocyte-macrophage colony-stimulating factor, US Foods, Technology, COVID-19, Breast cancer, SEC, Research, Marketing, Coronavirus, DCH, MBBS, GD2, Failure, Government, MRCP, Company, All India Mahila Congress, Neurotoxicity, Naxitamab, Industry, Annual report, Neuropathic pain, MSK, Patient, Bronchospasm, Anaphylaxis, Transverse myelitis, Hypotension, Medical device, Pharmaceutical industry, MD

The Y-mAbs research and development day will feature presentations from oncology key opinion leaders (KOLs) Javier E. Oesterheld, M.D.

Key Points: 
  • The Y-mAbs research and development day will feature presentations from oncology key opinion leaders (KOLs) Javier E. Oesterheld, M.D.
  • An update on Y-mAbs broad and advanced product pipeline, including the Companys SADA Technology, will follow from Vignesh Rajah, MBBS, DCH, MRCP(UK), MBA, (SVP, Chief Medical Officer at Y-mAbs) and Steen Lisby, M.D., DMSc, (SVP, Chief Scientific Officer at Y-mAbs).
  • Dr. Lisby will present new details on the proposed mechanism of action for the SADA Technology.
  • The Company plans to file an Investigational New Drug Application (IND) with the US Food & Drug Administration (FDA) for GD2-SADA by the end of this year.

Y-mAbs Announces Pipeline Update

Retrieved on: 
Wednesday, December 15, 2021
Therapy, Melanoma, Doctor of Philosophy, Private Securities Litigation Reform Act, Cardiac arrest, Neoplasm, Bone marrow, MBA, Squamous cell carcinoma, Antibody, FDA, Neuroblastoma, Cancer, Stridor, Growth, Adult, Hospital, Wernicke encephalopathy, Atrium, SVP, Memorial Sloan Kettering Cancer Center, Safety, Risk, GLOBE, Sarcoma, Granulocyte-macrophage colony-stimulating factor, US Foods, Technology, COVID-19, Breast cancer, SEC, Research, Marketing, Coronavirus, DCH, MBBS, GD2, Failure, Government, MRCP, Company, All India Mahila Congress, Neurotoxicity, Naxitamab, Industry, Annual report, Neuropathic pain, MSK, Patient, Bronchospasm, Anaphylaxis, Transverse myelitis, Hypotension, Medical device, Pharmaceutical industry, MD

The Y-mAbs research and development day will feature presentations from oncology key opinion leaders (KOLs) Javier E. Oesterheld, M.D.

Key Points: 
  • The Y-mAbs research and development day will feature presentations from oncology key opinion leaders (KOLs) Javier E. Oesterheld, M.D.
  • An update on Y-mAbs broad and advanced product pipeline, including the Companys SADA Technology, will follow from Vignesh Rajah, MBBS, DCH, MRCP(UK), MBA, (SVP, Chief Medical Officer at Y-mAbs) and Steen Lisby, M.D., DMSc, (SVP, Chief Scientific Officer at Y-mAbs).
  • Dr. Lisby will present new details on the proposed mechanism of action for the SADA Technology.
  • Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

UpCounsel Raises $3.9M from Retail Investors, Makes History as Wefunder’s Highest Regulation Crowdfund for Female CEO

Retrieved on: 
Friday, December 10, 2021
Technology, Legal, Human Resources, Finance, Consumer, Consulting, Professional Services, Other Philanthropy, Philanthropy, Public Relations, Investor Relations, Software, Communications, Internet, Women, Postmates, CEO, Stanford University, Female, Silicon, Atrium, Y Combinator, Leadership, News, Private investigator

UpCounsel CEO KJ Erickson, a 4-time founder and Y Combinator, Stanford and Oxford Alumna, became the first female CEO to raise over $3.9M in a Regulation Crowdfunding campaign on Wefunder, the most popular retail investor platform in the United States.

Key Points: 
  • UpCounsel CEO KJ Erickson, a 4-time founder and Y Combinator, Stanford and Oxford Alumna, became the first female CEO to raise over $3.9M in a Regulation Crowdfunding campaign on Wefunder, the most popular retail investor platform in the United States.
  • The original iteration of UpCounsel announced it was shutting down in February of 2020 despite serving millions of users and enterprise clients like Postmates, Hotel Tonight, and Airbnb.
  • Under new leadership, UpCounsel achieved profitability, tripled revenues, and saved users over $12M in legal fees.
  • With this fresh injection of capital, UpCounsel is strongly positioned to disrupt the legal technology industry, creating Legal You Can Love.

UpCounsel, Leading Legal Services Marketplace, Achieves Profitability and Raises $3,300,000 from Retail Investors

Retrieved on: 
Tuesday, December 7, 2021
Software, Networks, Internet, Fund Raising, Women, Technology, Legal, Insurance, Family, Finance, Consulting, Banking, Consumer, Professional Services, Philanthropy, Mobile, Wireless, Marketing, Courts, Communications, Small Business, Other Policy Issues, Labor, Search Engine Optimization, Search Engine Marketing, Public Policy, Government, Blogging, Other Philanthropy, Other Technology, People, Growth, Leadership, Stanford University, Female, News, CEO, Atrium, Y Combinator, United, Postmates, LTV, Cryptocurrency

Since the campaigns launch, UpCounsel has raised $3.3M from 1,600+ retail investors.

Key Points: 
  • Since the campaigns launch, UpCounsel has raised $3.3M from 1,600+ retail investors.
  • With only 2 days left in the campaign, UpCounsel is gearing up to take on the fast-growing legal technology market, which is slated to surpass $25B in 2025.
  • In its first year under the new leadership, UpCounsel cemented its value proposition, achieved profitability, tripled revenues, and saved users over $12M in legal fees.
  • To learn more about UpCounsel and its mission to Bring Legal to the People, as well as how to invest, please visit https://wefunder.com/upcounsel .

Y-mAbs Hosting Virtual Research and Development Day

Retrieved on: 
Monday, December 6, 2021
Risk, SEC, Technology, Failure, Neurotoxicity, Coronavirus, Therapy, American Society of Clinical Oncology, Acute leukemia, PRV, Annual report, Hematology, MBA, SVP, GLOBE, Private Securities Litigation Reform Act, Patient, Industry, ASCO, AECC, Atrium, DCH, Cancer, Marketing, YIA, Company, Hospital, Growth, CDA, Anaphylaxis, Bone marrow, Transverse myelitis, Government, Neuropathic pain, Levine, MBBS, MRCP, FDA, Neoplasm, GD2, Society, Granulocyte-macrophage colony-stimulating factor, Research, Sarcoma, Safety, Cardiac arrest, COVID-19, Adult, All India Mahila Congress, Sale, Association, Medicine, Pharmaceutical industry

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that it will host a virtual research and development day on Wednesday, December 15, 2021 at 12pm Eastern Time.

Key Points: 
  • NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that it will host a virtual research and development day on Wednesday, December 15, 2021 at 12pm Eastern Time.
  • The Y-mAbs research and development day will feature presentations from oncology key opinion leaders (KOLs) Javier E. Oesterheld, M.D.
  • Hes also the principal investigator for Carolinas Kids Cancer Research Coalition, in conjunction with the developmental therapeutics program at Levine Childrens Hospital.
  • Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Holland America Line's Rotterdam Sets Sail with World-Class Floating Art Gallery Valued at Over $4.1 Million

Retrieved on: 
Wednesday, October 27, 2021
HAL, Collection (artwork), Pepper, CCL, Marketing, Holland America Line, COVID-19, Health, Travel, Mississauga Music Walk of Fame, Atrium, Billie Holiday, Animal, Photography, CUK, Collection, B.B. King Museum, YSA, NYSE, Sound, Artlink, Movement, Paint, Korea, Architecture, Zoology, Music, Sculpture, Andy Picci, Atmosphere, Yukon, Crow, Color, Cell, America Line, Rolling Stone, Interior design, Cruise line

SEATTLE, Oct. 27, 2021 /PRNewswire/ --Holland America Line ships have long been regarded as floating art galleries for their extensive collections of museum-quality pieces.

Key Points: 
  • SEATTLE, Oct. 27, 2021 /PRNewswire/ --Holland America Line ships have long been regarded as floating art galleries for their extensive collections of museum-quality pieces.
  • Eight historical paintings are now on Rotterdam, including depictions of Rotterdam I, Rotterdam II, Rotterdam III, Rotterdam IV and Rotterdam V. The ship also hosts three previous Rotterdam ship models, and the bell from Rotterdam VI can be found in the Crow's Nest.
  • Ghadyanloo recently had solo exhibitions in Almine Rech's galleries in Paris and Brussels, and now Holland America Line guests can enjoy his captivating art.
  • In light of COVID-19, Holland America Line is currently enhancing health and safety protocols and how they may impact future cruises.

Atrium HR Consulting ramps up investment to meet demand for global mental health resources

Retrieved on: 
Wednesday, September 22, 2021
Grief, HR, Consultant, Workplace, Atrium, Child, Psychology, Mental health, Medicine

HONG KONG, Sept. 22, 2021 /PRNewswire/ -- Atrium HR Consulting ,part of Alliance Group International's portfolio, has cemented its position as the market leader in global mental health resources by implementing a major investment and growth strategy.

Key Points: 
  • HONG KONG, Sept. 22, 2021 /PRNewswire/ -- Atrium HR Consulting ,part of Alliance Group International's portfolio, has cemented its position as the market leader in global mental health resources by implementing a major investment and growth strategy.
  • As the world's first fully remote HR service covering the entire expatriate employee lifespan, Atrium has a unique insight into the ever-evolving mental health needs of the global workplace.
  • Director of Atrium HR Consulting, Gabrielle Ramsay-Smith explains, "We are proud of our exceptional service within the field of global mental health resources.
  • Atrium is committed to working closely with clients to deliver mental health assistance and continues to strive to introduce further innovations in the near future."